Is CyberArk The Next Big Cybersecurity Stock?
CyberArk Software (NASDAQ: CYBR) recently reported phenomenal quarter numbers, passing…
Buy
59
ITCI Quote, Financials, Valuation and Earnings
Last price:
$131.47
Seasonality move
:
6.95%
Day range:
$131.27 - $131.46
52-week range:
$63.87 - $131.46
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
19.92x
P/B ratio:
12.17x
Volume:
996.8K
Avg. volume:
2.2M
1-year change:
102.92%
Market cap:
$14B
Revenue:
$680.5M
EPS (TTM):
-$0.73
ITCI Analysts' Consensus Rating
The 11 analysts providing 12-month price projections for Intra-Cellular Therapies shares anticipate an average target of $132.00, ranging from a low estimate of $132.00 to a high estimate of $132.00. This average target implies a growth of 0.42% compared to the current stock price of $131.45.
Consensus Price Target
$132.00
Highest Price Target
$132.00
Lowest Price Target
$132.00
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Analyst Ratings
| 6M Ago | 1M Ago | Current | |
|---|---|---|---|
| Buy | 9 | 2 | 2 |
| Hold | 2 | 10 | 9 |
| Sell | 0 | 0 | 0 |
| Consensus | Buy | Hold | Hold |
ITCI Recommendation Trends
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is the Market Going to Go Lower?
The last month has been extremely difficult for the stock…
2 Dividend Stocks to Buy in a Recession
While many economists and investors initially expected 2025 to be…
Stock Ideas
Buy
53
Is AAPL Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 35x
Buy
54
Is NVDA Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 41x
Buy
51
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Alerts
Buy
52
RGC alert for Mar 18
Regencell Bioscience Holdings [RGC] is up 73.51% over the past day.
Buy
63
EXOD alert for Mar 18
Exodus Movement [EXOD] is down 3.96% over the past day.
Sell
45
MNPR alert for Mar 18
Monopar Therapeutics [MNPR] is up 0.93% over the past day.
